These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 9554372

  • 1. Miliary tuberculosis of the lung in a patient treated with bacillus Calmette-Guerin for superficial bladder cancer.
    Iantorno R, Nicolai M, Storto ML, Ciccotosto C, Cipollone G, Mastroprimiano G, Tenaglia RL.
    J Urol; 1998 May; 159(5):1639-40. PubMed ID: 9554372
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Bladder and penile lesions with inguinal adenopathy after intravesical Bacillus Calmette-Guerin (BCG) treatment.
    Yates J, Stein B.
    Urology; 2007 Dec; 70(6):1223.e15-7. PubMed ID: 18158061
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tubercular prostatic abscess as a complication of intravesical bacillus Calmette-Guérin immunotherapy.
    Aust TR, Massey JA.
    Int J Urol; 2005 Oct; 12(10):920-1. PubMed ID: 16323989
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The safety and efficacy of different doses of bacillus Calmette Guérin in superficial bladder transitional cell carcinoma.
    Agrawal MS, Agrawal M, Bansal S, Agarwal M, Lavania P, Goyal J.
    Urology; 2007 Dec; 70(6):1075-8. PubMed ID: 18158020
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Miliary tuberculosis after intravesical Bacillus Calmette-Guerin administration].
    Reparaz J, Uriz J, Castiello J, Sola J.
    Enferm Infecc Microbiol Clin; 1993 Dec; 11(10):570. PubMed ID: 8142511
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Urinary Interleukin-8 and 18 predict the response of superficial bladder cancer to intravesical therapy with bacillus Calmette-Guerin.
    Thalmann GN, Sermier A, Rentsch C, Möhrle K, Cecchini MG, Studer UE.
    J Urol; 2000 Dec; 164(6):2129-33. PubMed ID: 11061941
    [Abstract] [Full Text] [Related]

  • 15. Miliary lung disease after intravesical bacillus Calmette-Guérin immunotherapy.
    Jasmer RM, McCowin MJ, Webb WR.
    Radiology; 1996 Oct; 201(1):43-4. PubMed ID: 8816518
    [Abstract] [Full Text] [Related]

  • 16. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL, Blumenstein BA, Crissman JD, Montie JE, Gottesman JE, Lowe BA, Sarosdy MF, Bohl RD, Grossman HB, Beck TM, Leimert JT, Crawford ED.
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Miliary tuberculosis after intravesical Bacillus Calmette-Guerin immunotherapy.
    Şimşek A, Güler M, Günay S, Çapan N.
    Tuberk Toraks; 2013 Apr; 61(3):252-4. PubMed ID: 24298968
    [No Abstract] [Full Text] [Related]

  • 19. Miliary lung disease induced by intravesical Bacillus Calmette-Guérin treatment.
    Barankiewitz I, Manor H, Strauss S.
    Eur Radiol; 1999 Apr; 9(9):1933. PubMed ID: 10602981
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical investigation on the effect of intravesical instillation of antifibrinolytic agents with bacillus Calmette-Guerin on preventing bladder cancer recurrence].
    Ding GQ, Shen ZJ, Lu J, Jin XD, Chen J, Shi SF.
    Zhonghua Wai Ke Za Zhi; 2005 Nov 15; 43(22):1457-60. PubMed ID: 16318813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.